M&A Analysis

Approach

M&A Analysis

Cascade Research’s mission is to develop future dealmakers by equipping students with the analytical discipline, valuation skills, and commercial judgement essential for real-world M&A execution.

M&A Analysis Team

Jeremiah Z. Wang

Head of M&A Analysis

Helly Lourenço

Head of M&A Analysis

Henri Burkhard

M&A Analyst

Mohannad Kailani

M&A Analyst

Elliot Kahi

M&A Analyst

Alexandre Dore

M&A Analyst

Joel Agaba

M&A Analyst

Raghav Jaikumar

M&A Analyst

Fawad Hussain

M&A Analyst

Takeshi Shimazu

Senior Advisor

Structure of our Reports

Strategic Rationale: Evaluation of the transaction’s core logic, focusing on market synergy, operational integration, and the long-term strategic alignment of the combined entity.

Target Overview: A summary of the target company’s business model, key offerings, and the specific value it adds to the acquirer’s portfolio.

Deal Dynamics: Breakdown of the transaction structure, including purchase price, financing methods, and the resulting pro-forma ownership.

Accretion/Dilution Analysis: Evaluation of the deal’s impact on Earnings Per Share, synergy realisations, and the combined entity’s projected valuation.

Reports

Boston Scientific

Acquires

Penumbra

Deal Overview

Deal Size: $14.5B.

Industry: Medical Devices.

EBITDA Multiple: 60.3x EBITDA.

Financing: 73% Cash and 27% Stock transaction.

Chevron

Acquires

Hess

Deal Overview

Deal Size: $53B.

Industry: Oil & Gas.

EBITDA Multiple: 8.1x EBITDA.

Financing: 100% Stock Transaction.

Waystar

Acquires

Iodine

Deal Overview

Deal Size: $1.25B.

Industry: Health Care Technology.

EBITDA Multiple: 11.6x EBITDA.

Financing: 50% Cash and 50% Stock.

UnitedHealth Group

Acquires

Amedysis

Deal Overview

Deal Size: $3.3B.

Industry: Managed Health Care/Health Care Services.

EBITDA Multiple: 15.2x EBITDA.

Financing: 100% Cash Transaction.